TABLE 3.
TABLE 3. Proportion (and 95% CI) of PLUS Users by Group and by Trial Phase
| Study Group | Baseline | Intervention Period | Control-Crossover Period |
|---|---|---|---|
| Full-Serve (n = 98) | 72.45 (62.9, 80.3) | 87.8 (79.8, 92.9) | 67.4 (57.6, 75.8) |
| Self-Serve (n = 105) | 72.38 (63.2, 80.0) | 75.2 (66.2, 82.5) | 75.2 (66.2, 82.5) |
| Difference | 0.07 (−12.2, 12.2) | 12.5 (1.8, 22.9) | 7.89 (−4.51, 20.1) |